Strategies of porous network quinolone polymers: A comprehensive evaluation of their biological activity
Source abstract
Abstract
Abstract Hydrazine polymers were synthesized under the condition of hydrazine hydrate/ethanol by a clever one-pot method, and then treated with methanesulfonyl chloride and acetyl chloride, respectively, two new quinolones were easily obtained. The basic structure characterization of the prepared quinolone polymers was established based on 1H NMR spectra of aromatic rings and branched chains. In terms of cell activity, MTT assay was used to study the anti-proliferation properties of HCT-116, A549, HepG-2, and McF-7 human cancer cell lines and normal cell lines L02 compared with positive control 5-FU.The distribution and nucleation of polymeric drugs in cells were further observed by means of cell imaging. Conventional Annexin V-FITC kit was subsequently used to detect cell cycle arrest with propidium iodide (PI)and to monitor apoptosis induction with flow cytometry. The results showed that both of the novel quinolone polymers had strong cytotoxic compounds to induce cell cycle stop and trigger apoptosis in the G2/M phase in different test cancer cells. In particular, polymer 1 was more effective.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Analytical Chemistry and Sensors · Luminescence and Fluorescent Materials · Cancer therapeutics and mechanisms
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (50)
Show source-provided references
1. Cancer therapies utilizing the camptothecins: a review of the in vivo literature10.1021/mp900243b ↗
2. Efficient gene delivery to human umbilical cord mesenchymal stem cells by cationized Porphyra yezoensis polysaccharide nanoparticles
3. Quercetin-loaded freeze-dried nanomicelles: improving absorption and anti-glioma efficiency in vitro and in vivo10.1016/j.jconrel.2016.05.045 ↗
4. Preparation and evaluation of icariside II-loaded binary mixed micelles using Solutol HS15 and Pluronic F127 as carriers10.3109/10717544.2016.1167270 ↗
5. Recent advances in the application of vitamin ETPGS for drug delivery10.7150/thno.22711 ↗
6. Enhanced oral bioavailability, reduced irritation and increased hypolipidemic activity of self-assembled capsaicin prodrug nanoparticles10.1016/j.jff.2018.03.006 ↗
7. Nanomedicine against malaria10.2174/09298673113206660292 ↗
8. Improved oral bioavailability of capsaicin via liposomal nanoformulation: preparation, in vitro drug release and pharmacokinetics in rats10.1007/s12272-014-0481-7 ↗
9. Anti-listeria effects of chitosan-coated nisin-silica liposome on Cheddar cheese10.3168/jds.2016-11658 ↗
10. Control of Staphylococcus aureus on soya bean products by D-amino acids/nutmeg essential oil-co-loaded nanofilms10.1111/ijfs.13523 ↗
11. Cancer nanomedicine: progress, challenges and opportunities10.1038/nrc.2016.108 ↗
12. Improving anti-listeria activity of cheese packaging via nanofiber containing nisin-loaded nanoparticles10.1016/j.lwt.2017.04.003 ↗
13. Synthesized zinc peroxide nanoparticles (ZnO2-NPs): a novel antimicrobial, anti-elastase, anti-keratinase, and anti-inflammatory approach toward polymicrobial burn wounds10.2147/IJN.S141201 ↗
14. Enhancing antibacterial efficacy of nisin in pork by poly--glutamic acid/poly-l-lysine nanoparticles encapsulation10.1111/jfs.12475 ↗
15. Fabrication of chitosan nanofibers containing tea tree oil liposomes against Salmonella spp. in chicken10.1016/j.lwt.2018.06.026 ↗
16. Enhanced oral bioavailability and tissue distribution of a new potential anticancer agent, flammulina velutipes sterols, through liposomal encapsulation10.1021/jf3055278 ↗
17. Polymer-based prodrugs: improving tumor targeting and the solubility of small molecule drugs in cancer therapy10.3390/molecules201219804 ↗
18. Breaking down the barriers to precision cancer nanomedicine10.1016/j.tibtech.2016.07.006 ↗
19. Newly designed silica-containing redox nanoparticles for oral delivery of novel TOP2 catalytic inhibitor for treating colon cancer10.1002/adhm.201700428 ↗
20. Bioactive glass and PLGA composite microspheres, a promising efficient carrier for exenatide delivery
21. Insight into cellular uptake and intracellular trafficking of nanoparticles10.1186/s11671-018-2728-6 ↗
22. Core-shell structured Fe3O4@TiO2-doxorubicin nanoparticles for targeted chemo-sonodynamic therapy of cancer10.1016/j.ijpharm.2015.03.070 ↗
23. Targeted nanomedicine for cancer therapeutics: towards precision medicine overcoming drug resistance10.1016/j.drup.2017.05.002 ↗
24. A functional iron oxide nanoparticles modified with PLA-PEG-DG as tumor-targeted MRI contrast agent10.1007/s11095-017-2165-8 ↗
25. Nanomedicine for tumor microenvironment modulation and cancer treatment enhancement10.1016/j.nantod.2018.06.008 ↗
26. Stimuli-responsive nanotherapeutics for precision drug delivery and cancer therapy10.1002/wnan.1527 ↗
27. Rational design of cancer nanomedicine for simultaneous stealth surface and enhanced cellular uptake
28. A novel water soluble ligand bridged cobalt(II) coordination polymer of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (isonicotinic) hydrazone: evaluation of the DNA binding, protein interaction, radical scavenging and anticancer activity10.1039/c2dt12274j ↗
29. Rational design of cancer nanomedicine: nanoproperty integration and synchronization10.1002/adma.201606628 ↗
30. Anticancer polymers designed for killing dormant prostate cancer cells10.1038/s41598-018-36608-5 ↗
31. Quinolone hybrids and their anti-cancer activities: an overview10.1016/j.ejmech.2019.01.017 ↗
32. Preparation and characterization of rod-like chitosan-quinoline nanoparticles as pH-responsive nanocarriers for quercetin delivery10.1016/j.ijbiomac.2019.01.137 ↗
33. Current trends and future directions of fluoroquinolones10.2174/0929867325666180214122944 ↗
34. Quinolone hybrids and their anti-cancer activities: an overview10.1016/j.ejmech.2019.01.017 ↗
35. Comprehensive review on current developments of quinoline-based anticancer agents10.1016/j.arabjc.2016.10.009 ↗
36. Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways10.1016/j.bcp.2007.03.015 ↗
37. Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways10.1016/j.bcp.2007.03.015 ↗
38. Structural simplification of bioactive natural products with multicomponent synthesis. 2. Antiproliferative and antitubulin activities of pyrano[3,2-c]pyridones and pyrano[3,2-c]quinolones10.1021/jm701499n ↗
39. Novel quinolone CHM-1 induces apoptosis and inhibits metastasis in a human osterogenic sarcoma cell line10.1002/jor.20937 ↗
40. Phase II multicenter trial of voreloxin as second-line therapy in chemotherapy-sensitive or refractory small cell lung cancer10.1097/JTO.0b013e318200e509 ↗
41. Synthesis and anticancer activity of novel curcumin-quinolone hybrids10.1016/j.bmcl.2015.06.068 ↗
42. Quinolone-indolone conjugate induces apoptosis by inhibiting the EGFR-STAT3-HK2 pathway in human cancer cells10.3892/mmr.2015.3716 ↗
43. Procyanidins, from Castanea mollissima Bl. shell, induces autophagy following apoptosis associated with PI3K/AKT/mTOR inhibition in HepG2 cells, Biomed
44. Apigenin inhibits cell proliferation, migration, and invasion by targeting Akt in the A549 human lung cancer cell line10.1097/CAD.0000000000000479 ↗
45. Acquisition of meiotic competence in mouse oocytes: absolute amounts of p34(cdc 2), cyclin b1, cdc25C, and wee 1 in meiotically incompetent and competent oocytes10.1095/biolreprod63.6.1610 ↗
46. Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer10.3748/wjg.v9.i10.2341 ↗
47. Activation of cyclin B1-Cdk1 synchronizes events in the nucleus and the cytoplasm at mitosis10.1083/jcb.200909144 ↗
48. 2-(3-fluorophenyl)-6-methoxyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (YJC-1) induces mitotic phase arrest in A549 cells10.1016/j.ejphar.2006.12.001 ↗
49. Induction of mitotic arrest and apoptosis by a novel synthetic quinolone analogue, CWC-8, via intrinsic and extrinsic apoptotic pathways in human osteogenic sarcoma U-2 OS cells
50. Effect of evodiamine on the proliferation and apoptosis of A549 human lung cancer cells10.3892/mmr.2016.5575 ↗